Pandemic Effect: Sponsors Paid Far Fewer User Fees Than Expected In FY 2020

Revenue down
Fewer submissions in FY 2020 meant less user fee revenue for the FDA. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from User Fees

More from Pathways & Standards